BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35929787)

  • 1. Clinical event rate in patients with and without left main disease undergoing isolated coronary artery bypass grafting: results from the European DuraGraft Registry.
    Caliskan E; Misfeld M; Sandner S; Böning A; Aramendi J; Salzberg SP; Choi YH; Perrault LP; Tekin I; Cuerpo GP; Lopez-Menendez J; Weltert LP; Böhm J; Krane M; González-Santos JM; Tellez JC; Holubec T; Ferrari E; Emmert MY;
    Eur J Cardiothorac Surg; 2022 Sep; 62(4):. PubMed ID: 35929787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel endothelial damage inhibitor for the treatment of vascular conduits in coronary artery bypass grafting: protocol and rationale for the European, multicentre, prospective, observational DuraGraft registry.
    Caliskan E; Sandner S; Misfeld M; Aramendi J; Salzberg SP; Choi YH; Satishchandran V; Iyer G; Perrault LP; Böning A; Emmert MY
    J Cardiothorac Surg; 2019 Oct; 14(1):174. PubMed ID: 31615560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes and quality of life after contemporary isolated coronary bypass grafting: a prospective cohort study.
    Sandner S; Misfeld M; Caliskan E; Böning A; Aramendi J; Salzberg SP; Choi YH; Perrault LP; Tekin I; Cuerpo GP; Lopez-Menendez J; Weltert LP; Böhm J; Krane M; González-Santos JM; Tellez JC; Holubec T; Ferrari E; Doros G; Vitarello CJ; Emmert MY;
    Int J Surg; 2023 Apr; 109(4):707-715. PubMed ID: 36912566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].
    Yang BG; Yu XP; Chen F; Lyu SZ; Li Q; He JQ; Yuan F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):19-25. PubMed ID: 28100341
    [No Abstract]   [Full Text] [Related]  

  • 5. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
    Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
    Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial.
    Kappetein AP; Head SJ; Morice MC; Banning AP; Serruys PW; Mohr FW; Dawkins KD; Mack MJ;
    Eur J Cardiothorac Surg; 2013 May; 43(5):1006-13. PubMed ID: 23413014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matched Analysis of Surgical Versus Percutaneous Revascularization for Left Main Coronary Disease.
    Huckaby LV; Sultan I; Ferdinand FD; Mulukutla S; Kapoor S; Thoma F; Wang Y; Kilic A
    Ann Thorac Surg; 2022 Mar; 113(3):800-807. PubMed ID: 33930354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left Main Revascularization With PCI or CABG in Patients With Chronic Kidney Disease: EXCEL Trial.
    Giustino G; Mehran R; Serruys PW; Sabik JF; Milojevic M; Simonton CA; Puskas JD; Kandzari DE; Morice MC; Taggart DP; Gershlick AH; Généreux P; Zhang Z; McAndrew T; Redfors B; Ragosta M; Kron IL; Dressler O; Leon MB; Pocock SJ; Ben-Yehuda O; Kappetein AP; Stone GW
    J Am Coll Cardiol; 2018 Aug; 72(7):754-765. PubMed ID: 30092952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impacts of the SYNTAX score I, II and SYNTAX score II 2020 on left main revascularization.
    Sung WT; Chuang MJ; Tsai YL; Chou RH; Chang CC; Huang PH
    Sci Rep; 2024 Jan; 14(1):1073. PubMed ID: 38212627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein and prognosis after percutaneous coronary intervention and bypass graft surgery for left main coronary artery disease: Analysis from the EXCEL trial.
    Kosmidou I; Redfors B; Chen S; Crowley A; Lembo NJ; Karmpaliotis D; Brown WM; Maupas E; Durrleman N; Shah A; Reardon MJ; Dressler O; Ben-Yehuda O; Kappetein AP; Sabik JF; Serruys PW; Stone GW
    Am Heart J; 2019 Apr; 210():49-57. PubMed ID: 30738244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bypass Surgery or Stenting for Left Main Coronary Artery Disease in Patients With Diabetes.
    Milojevic M; Serruys PW; Sabik JF; Kandzari DE; Schampaert E; van Boven AJ; Horkay F; Ungi I; Mansour S; Banning AP; Taggart DP; Sabaté M; Gershlick AH; Bochenek A; Pomar J; Lembo NJ; Noiseux N; Puskas JD; Crowley A; Kosmidou I; Mehran R; Ben-Yehuda O; Généreux P; Pocock SJ; Simonton CA; Stone GW; Kappetein AP
    J Am Coll Cardiol; 2019 Apr; 73(13):1616-1628. PubMed ID: 30947913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left Main Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Prior Cerebrovascular Disease: Results From the EXCEL Trial.
    Diamond J; Madhavan MV; Sabik JF; Serruys PW; Kappetein AP; Leon MB; Taggart DP; Berland J; Morice MC; Gersh BJ; Kandzari DE; Dressler O; Stone GW
    JACC Cardiovasc Interv; 2018 Dec; 11(24):2441-2450. PubMed ID: 30573053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness analysis of percutaneous coronary intervention versus coronary artery bypass grafting in patients with chronic kidney disease and unprotected left main coronary artery disease.
    Kim DW; Om SY; Park MW; Park HW; Lee PH; Kang DY; Ahn JM; Lee CW; Park SW; Park SJ; Her SH; Park DW
    EuroIntervention; 2020 May; 16(1):27-35. PubMed ID: 31380780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease: The EXCEL Trial.
    Kosmidou I; Chen S; Kappetein AP; Serruys PW; Gersh BJ; Puskas JD; Kandzari DE; Taggart DP; Morice MC; Buszman PE; Bochenek A; Schampaert E; Pagé P; Sabik JF; McAndrew T; Redfors B; Ben-Yehuda O; Stone GW
    J Am Coll Cardiol; 2018 Feb; 71(7):739-748. PubMed ID: 29447735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-culprit left main coronary artery disease in acute myocardial infarction complicated by cardiogenic shock.
    Park IH; Jang WJ; Oh JH; Yang JH; Song YB; Hahn JY; Choi SH; Gwon HC; Ahn CM; Yu CW; Kim HJ; Bae JW; Kwon SU; Lee HJ; Lee WS; Jeong JO; Park SD
    PLoS One; 2023; 18(3):e0276711. PubMed ID: 36996239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous coronary intervention vs. coronary artery bypass grafting for left main revascularization: an updated meta-analysis.
    Bajaj NS; Patel N; Kalra R; Marogil P; Bhardwaj A; Arora G; Arora P
    Eur Heart J Qual Care Clin Outcomes; 2017 Jul; 3(3):173-182. PubMed ID: 28838092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of patients with and without baseline lipid-lowering therapy undergoing revascularization for left main coronary artery disease: analysis from the EXCEL trial.
    Chen S; Redfors B; Liu Y; Vrolix M; Macaya C; Ben-Yehuda O; Kappetein AP; Sabik JF; Serruys PW; Stone GW
    Coron Artery Dis; 2019 Mar; 30(2):143-149. PubMed ID: 30531253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Coronary Artery Bypass Grafting and Drug-Eluting Stents in Patients with Left Main Coronary Artery Disease and Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
    Barbarawi M; Zayed Y; Hamid K; Kheiri B; Barbarawi O; Sundus S; Rashdan L; Alabdouh A; Chahine A; Bachuwa G; Alkotob ML
    Cardiovasc Revasc Med; 2019 Dec; 20(12):1184-1189. PubMed ID: 30842042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of Discharge Resting Heart Rate to Predict Adverse Cardiovascular Outcomes in Patients With Left Main Coronary Artery Disease Revascularized With Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting (from the EXCEL Trial).
    Kosmidou I; Crowley A; Macedo L; Ben-Yehuda O; Gersh BJ; Boonstra PW; Kappetein AP; Serruys PW; Sabik JF; Stone GW
    Am J Cardiol; 2020 Jan; 125(2):169-175. PubMed ID: 31735328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential Event Rates and Independent Predictors of Long-Term Major Cardiovascular Events and Death in 5795 Patients With Unprotected Left Main Coronary Artery Disease Treated With Stents, Bypass Surgery, or Medication: Insights From a Large International Multicenter Registry.
    Kang SH; Ahn JM; Lee CH; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
    Circ Cardiovasc Interv; 2017 Jul; 10(7):. PubMed ID: 28701487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.